"Premenstrual Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Descriptor ID |
D011293
|
| MeSH Number(s) |
C23.550.568.968
|
| Concept/Terms |
Premenstrual Syndrome- Premenstrual Syndrome
- Premenstrual Syndromes
- Syndrome, Premenstrual
- Syndromes, Premenstrual
Premenstrual Tension- Premenstrual Tension
- Premenstrual Tensions
- Tension, Premenstrual
- Tensions, Premenstrual
|
Below are MeSH descriptors whose meaning is more general than "Premenstrual Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Premenstrual Syndrome".
This graph shows the total number of publications written about "Premenstrual Syndrome" by people in this website by year, and whether "Premenstrual Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Premenstrual Syndrome" by people in Profiles.
-
Nayyar S, Archibong A, Nayyar T. Testosterone and Prolactin Perturbations Possibly Associated with Reduced Levels of ?-Arrestin1 in Mononuclear Leukocytes of Women with Premenstrual Dysphoric Disorder. Int J Mol Sci. 2023 Oct 22; 24(20).
-
Nillni YI, Pineles SL, Rohan KJ, Zvolensky MJ, Rasmusson AM. The influence of the menstrual cycle on reactivity to a CO2 challenge among women with and without premenstrual symptoms. Cogn Behav Ther. 2017 04; 46(3):239-249.
-
Manikandan S, Nillni YI, Zvolensky MJ, Rohan KJ, Carkeek KR, Leyro TM. The role of emotion regulation in the experience of menstrual symptoms and perceived control over anxiety-related events across the menstrual cycle. Arch Womens Ment Health. 2016 12; 19(6):1109-1117.
-
Alam F, Nayyar S, Richie W, Archibong A, Nayyar T. Beta-Arrestin1 Levels in Mononuclear Leukocytes Support Depression Scores for Women with Premenstrual Dysphoric Disorder. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010043.
-
Mahon JN, Rohan KJ, Nillni YI, Zvolensky MJ. The role of perceived control over anxiety in prospective symptom reports across the menstrual cycle. Arch Womens Ment Health. 2015 Apr; 18(2):239-246.
-
Nillni YI, Rohan KJ, Mahon JN, Pineles SL, Zvolensky MJ. The role of anxiety sensitivity in the experience of menstrual-related symptoms reported via daily diary. Psychiatry Res. 2013 Dec 15; 210(2):564-9.
-
Nillni YI, Rohan KJ, Zvolensky MJ. The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO(2) challenge. Arch Womens Ment Health. 2012 Dec; 15(6):413-22.
-
Locklear TD, Huang Y, Frasor J, Doyle BJ, Perez A, Gomez-Laurito J, Mahady GB. Estrogenic and progestagenic effects of extracts of Justicia pectoralis Jacq., an herbal medicine from Costa Rica used for the treatment of menopause and PMS. Maturitas. 2010 Jul; 66(3):315-22.
-
Nillni YI, Rohan KJ, Bernstein A, Zvolensky MJ. Premenstrual distress predicts panic-relevant responding to a CO2 challenge among young adult females. J Anxiety Disord. 2010 May; 24(4):416-22.
-
Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry. 1993 Nov 15; 34(10):676-86.